{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:49:04Z","timestamp":1791910144929,"version":"4.3.4"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,8,10]],"date-time":"2011-08-10T00:00:00Z","timestamp":1312934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,8,10]],"date-time":"2011-08-10T00:00:00Z","timestamp":1312934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1038\/ejhg.2011.155","type":"journal-article","created":{"date-parts":[[2011,8,10]],"date-time":"2011-08-10T10:27:02Z","timestamp":1312972022000},"page":"134-140","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Cerebral cavernous malformations: from molecular pathogenesis to genetic counselling and clinical management"],"prefix":"10.1038","volume":"20","author":[{"given":"Remco A","family":"Haasdijk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke J","family":"Maat-Kievit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henricus J","family":"Duckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,10]]},"reference":[{"key":"BFejhg2011155_CR1","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1242\/dmm.000513","volume":"1","author":"AV Gore","year":"2008","unstructured":"Gore AV, Lampugnani MG, Dye L et al: Combinatorial interaction between CCM pathway genes precipitates hemorrhagic stroke. Dis Model Mech 2008; 1: 275\u2013281.","journal-title":"Dis Model Mech"},{"key":"BFejhg2011155_CR2","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S1474-4422(07)70053-4","volume":"6","author":"P Labauge","year":"2007","unstructured":"Labauge P, Denier C, Bergametti F et al: Genetics of cavernous angiomas. Lancet Neurol 2007; 6: 237\u2013244.","journal-title":"Lancet Neurol"},{"key":"BFejhg2011155_CR3","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1136\/jmg.2006.041079","volume":"43","author":"N Revencu","year":"2006","unstructured":"Revencu N, Vikkula M : Cerebral cavernous malformation: new molecular and clinical insights. J Med Genet 2006; 43: 716\u2013721.","journal-title":"J Med Genet"},{"key":"BFejhg2011155_CR4","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.3171\/foc.2006.21.1.3","volume":"21","author":"SR Dashti","year":"2006","unstructured":"Dashti SR, Hoffer A, Hu YC et al: Molecular genetics of familial cerebral cavernous malformations. Neurosurg Focus 2006; 21: e2.","journal-title":"Neurosurg Focus"},{"key":"BFejhg2011155_CR5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1056\/NEJM198808113190605","volume":"319","author":"D Rigamonti","year":"1988","unstructured":"Rigamonti D, Hadley MN, Drayer BP et al: Cerebral cavernous malformations. Incidence and familial occurrence. N Engl J Med 1988; 319: 343\u2013347.","journal-title":"N Engl J Med"},{"key":"BFejhg2011155_CR6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1055\/s-2006-933537","volume":"67","author":"U Felbor","year":"2006","unstructured":"Felbor U, Sure U, Grimm T et al: Genetics of cerebral cavernous angioma. Zentralbl Neurochir 2006; 67: 110\u2013116.","journal-title":"Zentralbl Neurochir"},{"issue":"Spec. no. 2","key":"BFejhg2011155_CR7","doi-asserted-by":"publisher","first-page":"R140","DOI":"10.1093\/hmg\/ddm211","volume":"16","author":"P Brouillard","year":"2007","unstructured":"Brouillard P, Vikkula M : Genetic causes of vascular malformations. Hum Mol Genet 2007; 16 (Spec. no. 2): R140\u2013R149.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2011155_CR8","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1161\/01.STR.0000157586.20479.fd","volume":"36","author":"J Gault","year":"2005","unstructured":"Gault J, Shenkar R, Recksiek P et al: Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion. Stroke 2005; 36: 872\u2013874.","journal-title":"Stroke"},{"key":"BFejhg2011155_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1148\/radiology.214.1.r00ja19209","volume":"214","author":"L Brunereau","year":"2000","unstructured":"Brunereau L, Labauge P, Tournier-Lasserve E et al: Familial form of intracranial cavernous angioma: MR imaging findings in 51 families. Radiology 2000; 214: 209\u2013216.","journal-title":"Radiology"},{"key":"BFejhg2011155_CR10","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1212\/WNL.57.10.1825","volume":"57","author":"P Labauge","year":"2001","unstructured":"Labauge P, Brunereau L, Laberge S et al: Prospective follow-up of 33 asymptomatic patients with familial cerebral cavernous malformations. Neurology 2001; 57: 1825\u20131828.","journal-title":"Neurology"},{"key":"BFejhg2011155_CR11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1600-0404.1998.tb07315.x","volume":"98","author":"AM Siegel","year":"1998","unstructured":"Siegel AM : Familial cavernous angioma: an unknown, known disease. Acta Neurol Scand 1998; 98: 369\u2013371.","journal-title":"Acta Neurol Scand"},{"key":"BFejhg2011155_CR12","first-page":"82","volume":"35","author":"P Otten","year":"1989","unstructured":"Otten P, Pizzolato GP, Rilliet B et al: [131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies]. Neurochirurgie 1989; 35: 82\u201383, 128\u2013131.","journal-title":"Neurochirurgie"},{"key":"BFejhg2011155_CR13","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3171\/jns.1994.80.3.0422","volume":"80","author":"JM Zabramski","year":"1994","unstructured":"Zabramski JM, Wascher TM, Spetzler RF et al: The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg 1994; 80: 422\u2013432.","journal-title":"J Neurosurg"},{"key":"BFejhg2011155_CR14","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3171\/jns.1987.67.4.0518","volume":"67","author":"D Rigamonti","year":"1987","unstructured":"Rigamonti D, Drayer BP, Johnson PC et al: The MRI appearance of cavernous malformations (angiomas). J Neurosurg 1987; 67: 518\u2013524.","journal-title":"J Neurosurg"},{"key":"BFejhg2011155_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/ana.10804","volume":"55","author":"C Denier","year":"2004","unstructured":"Denier C, Labauge P, Brunereau L et al: Clinical features of cerebral cavernous malformations patients with KRIT1 mutations. Ann Neurol 2004; 55: 213\u2013220.","journal-title":"Ann Neurol"},{"key":"BFejhg2011155_CR16","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1093\/hmg\/9.9.1351","volume":"9","author":"I Eerola","year":"2000","unstructured":"Eerola I, Plate KH, Spiegel R et al: KRIT1 is mutated in hyperkeratotic cutaneous capillary-venous malformation associated with cerebral capillary malformation. Hum Mol Genet 2000; 9: 1351\u20131355.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2011155_CR17","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/archopht.124.6.885","volume":"124","author":"P Labauge","year":"2006","unstructured":"Labauge P, Krivosic V, Denier C et al: Frequency of retinal cavernomas in 60 patients with familial cerebral cavernomas: a clinical and genetic study. Arch Ophthalmol 2006; 124: 885\u2013886.","journal-title":"Arch Ophthalmol"},{"key":"BFejhg2011155_CR18","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1111\/j.1468-3083.2009.03263.x","volume":"23","author":"J Sirvente","year":"2009","unstructured":"Sirvente J, Enjolras O, Wassef M et al: Frequency and phenotypes of cutaneous malformations in a consecutive series of 417 patients with familial cerebral cavernous malformations. J Eur Acad Dermatol Venereol 2009; 23: 1066\u20131072.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"BFejhg2011155_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nm.1918","volume":"15","author":"B Kleaveland","year":"2009","unstructured":"Kleaveland B, Zheng X, Liu JJ et al: Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway. Nat Med 2009; 15: 169\u2013176.","journal-title":"Nat Med"},{"key":"BFejhg2011155_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/13815","volume":"23","author":"S Laberge-le Couteulx","year":"1999","unstructured":"Laberge-le Couteulx S, Jung HH, Labauge P et al: Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet 1999; 23: 189\u2013193.","journal-title":"Nat Genet"},{"key":"BFejhg2011155_CR21","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1086\/380314","volume":"73","author":"CL Liquori","year":"2003","unstructured":"Liquori CL, Berg MJ, Siegel AM et al: Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet 2003; 73: 1459\u20131464.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2011155_CR22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1086\/426952","volume":"76","author":"F Bergametti","year":"2005","unstructured":"Bergametti F, Denier C, Labauge P et al: Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet 2005; 76: 42\u201351.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2011155_CR23","doi-asserted-by":"publisher","first-page":"e11740","DOI":"10.1371\/journal.pone.0011740","volume":"5","author":"CF Dibble","year":"2010","unstructured":"Dibble CF, Horst JA, Malone MH et al: Defining the functional domain of programmed cell death 10 through its interactions with phosphatidylinositol-3,4,5,-trisposphate. PLoS One 2010; 5: e11740.","journal-title":"PLoS One"},{"key":"BFejhg2011155_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/humu.9389","volume":"27","author":"CL Liquori","year":"2006","unstructured":"Liquori CL, Berg MJ, Squitieri F et al: Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus. Hum Mutat 2006; 27: 118.","journal-title":"Hum Mutat"},{"key":"BFejhg2011155_CR25","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.neuroscience.2008.05.030","volume":"155","author":"F Gianfrancesco","year":"2008","unstructured":"Gianfrancesco F, Esposito T, Penco S et al: ZPLD1 gene is disrupted in a patient with balanced translocation that exhibits cerebral cavernous malformations. Neuroscience 2008; 155: 345\u2013349.","journal-title":"Neuroscience"},{"key":"BFejhg2011155_CR26","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1111\/j.1742-4658.2009.07535.x","volume":"277","author":"F Riant","year":"2010","unstructured":"Riant F, Bergametti F, Ayrignac X et al: Recent insights into cerebral cavernous malformations: the molecular genetics of CCM. FEBS J 2010; 277: 1070\u20131075.","journal-title":"FEBS J"},{"key":"BFejhg2011155_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1227\/01.neu.0000440729.59133.c9","volume":"55","author":"J Gault","year":"2004","unstructured":"Gault J, Sarin H, Awadallah NA et al: Pathobiology of human cerebrovascular malformations: basic mechanisms and clinical relevance. Neurosurgery 2004; 55: 1\u201316; discussion 16\u201317.","journal-title":"Neurosurgery"},{"key":"BFejhg2011155_CR28","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1089\/lrb.2005.3.226","volume":"3","author":"QK Wang","year":"2005","unstructured":"Wang QK : Update on the molecular genetics of vascular anomalies. Lymphat Res Biol 2005; 3: 226\u2013233.","journal-title":"Lymphat Res Biol"},{"key":"BFejhg2011155_CR29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s11910-005-0063-7","volume":"5","author":"NW Plummer","year":"2005","unstructured":"Plummer NW, Zawistowski JS, Marchuk DA : Genetics of cerebral cavernous malformations. Curr Neurol Neurosci Rep 2005; 5: 391\u2013396.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"BFejhg2011155_CR30","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/humu.20996","volume":"30","author":"K Voss","year":"2009","unstructured":"Voss K, Stahl S, Hogan BM et al: Functional analyses of human and zebrafish 18-amino acid in-frame deletion pave the way for domain mapping of the cerebral cavernous malformation 3 protein. Hum Mutat 2009; 30: 1003\u20131011.","journal-title":"Hum Mutat"},{"key":"BFejhg2011155_CR31","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/ana.20947","volume":"60","author":"C Denier","year":"2006","unstructured":"Denier C, Labauge P, Bergametti F et al: Genotype-phenotype correlations in cerebral cavernous malformations patients. Ann Neurol 2006; 60: 550\u2013556.","journal-title":"Ann Neurol"},{"key":"BFejhg2011155_CR32","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1093\/hmg\/7.12.1851","volume":"7","author":"HD Craig","year":"1998","unstructured":"Craig HD, Gunel M, Cepeda O et al: Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. Hum Mol Genet 1998; 7: 1851\u20131858.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2011155_CR33","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/hmg\/ddn430","volume":"18","author":"AL Akers","year":"2009","unstructured":"Akers AL, Johnson E, Steinberg GK et al: Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet 2009; 18: 919\u2013930.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2011155_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/hmg\/ddq433","volume":"20","author":"DA McDonald","year":"2011","unstructured":"McDonald DA, Shenkar R, Shi C et al: A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease. Hum Mol Genet 2011; 20: 211\u2013222.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2011155_CR35","doi-asserted-by":"publisher","first-page":"e11786","DOI":"10.1371\/journal.pone.0011786","volume":"5","author":"L Goitre","year":"2010","unstructured":"Goitre L, Balzac F, Degani S et al: KRIT1 regulates the homeostasis of intracellular reactive oxygen species. PLoS One 2010; 5: e11786.","journal-title":"PLoS One"},{"key":"BFejhg2011155_CR36","doi-asserted-by":"publisher","first-page":"L1170","DOI":"10.1152\/ajplung.00168.2009","volume":"297","author":"J Belik","year":"2009","unstructured":"Belik J, Jerkic M, McIntyre BAS et al: Age-dependent endothelial nitric oxide synthase uncoupling in pulmonary arteries of endoglin heterozygous mice. Am J Physiol Lung Cell Mol Physiol 2009; 297: L1170\u2013L1178.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"BFejhg2011155_CR37","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1073\/pnas.1012617108","volume":"108","author":"A Louvi","year":"2011","unstructured":"Louvi A, Chen L, Two AM et al: Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology. PNAS 2011; 108: 3737\u20133742.","journal-title":"PNAS"},{"key":"BFejhg2011155_CR38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/35101031","volume":"1","author":"AG Knudson","year":"2001","unstructured":"Knudson AG : Two genetic hits (more or less) to cancer. Nat Rev Cancer 2001; 1: 157\u2013162.","journal-title":"Nat Rev Cancer"},{"issue":"Spec. no. 1","key":"BFejhg2011155_CR39","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1093\/hmg\/ddg103","volume":"12","author":"DA Marchuk","year":"2003","unstructured":"Marchuk DA, Srinivasan S, Squire TL et al: Vascular morphogenesis: tales of two syndromes. Hum Mol Genet 2003; 12 (Spec. no. 1): R97\u2013112.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2011155_CR40","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.yexcr.2008.10.006","volume":"315","author":"F Francalanci","year":"2009","unstructured":"Francalanci F, Avolio M, De Luca E et al: Structural and functional differences between KRIT1A and KRIT1B isoforms: a framework for understanding CCM pathogenesis. Exp Cell Res 2009; 315: 285\u2013303.","journal-title":"Exp Cell Res"},{"key":"BFejhg2011155_CR41","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/j.1742-4658.2009.07537.x","volume":"277","author":"E Faurobert","year":"2010","unstructured":"Faurobert E, Albiges-Rizo C : Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction. FEBS J 2010; 277: 1084\u20131096.","journal-title":"FEBS J"},{"key":"BFejhg2011155_CR42","doi-asserted-by":"publisher","first-page":"24099","DOI":"10.1074\/jbc.M110.128470","volume":"285","author":"X Li","year":"2010","unstructured":"Li X, Zhang R, Zhang H et al: Crystal structure of CCM3, a cerebral cavernous malformation protein critical for vascular integrity. J Biol Chem 2010; 285: 24099\u201324107.","journal-title":"J Biol Chem"},{"key":"BFejhg2011155_CR43","doi-asserted-by":"publisher","first-page":"34367","DOI":"10.1074\/jbc.M202468200","volume":"277","author":"CY Huang","year":"2002","unstructured":"Huang CY, Wu YM, Hsu CY et al: Caspase activation of mammalian sterile 20-like kinase 3 (Mst3). Nuclear translocation and induction of apoptosis. J Biol Chem 2002; 277: 34367\u201334374.","journal-title":"J Biol Chem"},{"key":"BFejhg2011155_CR44","doi-asserted-by":"publisher","first-page":"38405","DOI":"10.1074\/jbc.M605035200","volume":"281","author":"TJ Lu","year":"2006","unstructured":"Lu TJ, Lai WY, Huang CY et al: Inhibition of cell migration by autophosphorylated mammalian sterile 20-like kinase 3 (MST3) involves paxillin and protein-tyrosine phosphatase-PEST. J Biol Chem 2006; 281: 38405\u201338417.","journal-title":"J Biol Chem"},{"key":"BFejhg2011155_CR45","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1091\/mbc.e06-07-0608","volume":"18","author":"X Ma","year":"2007","unstructured":"Ma X, Zhao H, Shan J et al: PDCD10 interacts with Ste20-related kinase MST4 to promote cell growth and transformation via modulation of the ERK pathway. Mol Biol Cell 2007; 18: 1965\u20131978.","journal-title":"Mol Biol Cell"},{"key":"BFejhg2011155_CR46","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10048-007-0098-9","volume":"8","author":"K Voss","year":"2007","unstructured":"Voss K, Stahl S, Schleider E et al: CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations. Neurogenetics 2007; 8: 249\u2013256.","journal-title":"Neurogenetics"},{"key":"BFejhg2011155_CR47","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10048-010-0261-6","volume":"12","author":"E Schleider","year":"2011","unstructured":"Schleider E, Stahl S, W\u00fcstehube J et al: Evidence for anti-angiogenic and pro-survival functions of the cerebral cavernous malformation protein 3. Neurogenetics 2011; 12: 83\u201386.","journal-title":"Neurogenetics"},{"key":"BFejhg2011155_CR48","first-page":"ra26","volume":"3","author":"Y He","year":"2010","unstructured":"He Y, Zhang H, Yu L et al: Stabilization of VEGFR2 signalling by cerebral cavernous malformation 3 is critical for vascular development. Sci Signal 2010; 3: ra26.","journal-title":"Sci Signal"},{"key":"BFejhg2011155_CR49","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0925-4773(02)00209-5","volume":"117","author":"C Denier","year":"2002","unstructured":"Denier C, Gasc JM, Chapon F et al: Krit1\/cerebral cavernous malformation 1 mRNA is preferentially expressed in neurons and epithelial cells in embryo and adult. Mech Dev 2002; 117: 363\u2013367.","journal-title":"Mech Dev"},{"key":"BFejhg2011155_CR50","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1227\/01.NEU.0000114512.59624.A5","volume":"54","author":"O Guzeloglu-Kayisli","year":"2004","unstructured":"Guzeloglu-Kayisli O, Amankulor NM, Voorhees J et al: Krit1\/cerebral cavernous malformation 1 protein localizes to vascular endothelium, astrocytes, and pyramidal cells of the adult human cerebral cortex. Neurosurgery 2004; 54: 943\u2013949.","journal-title":"Neurosurgery"},{"key":"BFejhg2011155_CR51","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.modgep.2005.11.001","volume":"6","author":"N Petit","year":"2006","unstructured":"Petit N, Blecon A, Denier C et al: Patterns of expression of the three cerebral cavernous malformation (CCM) genes during embryonic and postnatal brain development. Gene Expr Patterns 2006; 6: 495\u2013503.","journal-title":"Gene Expr Patterns"},{"key":"BFejhg2011155_CR52","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1097\/00006123-200006000-00027","volume":"46","author":"JH Wong","year":"2000","unstructured":"Wong JH, Awad IA, Kim JH : Ultrastructural pathological features of cerebrovascular malformations: a preliminary report. Neurosurgery 2000; 46: 1454\u20131459.","journal-title":"Neurosurgery"},{"key":"BFejhg2011155_CR53","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.3171\/2010.6.FOCUS10125","volume":"29","author":"JK Burkhardt","year":"2010","unstructured":"Burkhardt JK, Schmidt D, Schoenauer R et al: Upregulation of transmembrane endothelial junction proteins in human cerebral cavernous malformations. Neurosurg Focus 2010; 29: E3.","journal-title":"Neurosurg Focus"},{"key":"BFejhg2011155_CR54","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1161\/01.STR.0000259914.21997.89","volume":"38","author":"Y Zhao","year":"2007","unstructured":"Zhao Y, Tan YZ, Zhou LF et al: Morphological observation and in vitro angiogenesis assay of endothelial cells isolated from human cerebral cavernous malformations. Stroke 2007; 38: 1313\u20131319.","journal-title":"Stroke"},{"key":"BFejhg2011155_CR55","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.devcel.2009.01.004","volume":"16","author":"E Dejana","year":"2009","unstructured":"Dejana E, Tournier-Lasserve E, Weinstein BM : The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell 2009; 16: 209\u2013221.","journal-title":"Dev Cell"},{"key":"BFejhg2011155_CR56","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1242\/dev.01036","volume":"131","author":"KJ Whitehead","year":"2004","unstructured":"Whitehead KJ, Plummer NW, Adams JA et al: Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations. Development 2004; 131: 1437\u20131448.","journal-title":"Development"},{"key":"BFejhg2011155_CR57","first-page":"702","volume":"2","author":"L Huang","year":"2003","unstructured":"Huang L, Ren J, Chen D et al: MUC1 cytoplasmic domain coactivates Wnt target gene transcription and confers transformation. Cancer Biol Ther 2003; 2: 702\u2013706.","journal-title":"Cancer Biol Ther"},{"key":"BFejhg2011155_CR58","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/1471-2164-7-197","volume":"7","author":"T Lang","year":"2006","unstructured":"Lang T, Hansson GC, Samuelsson T : An inventory of mucin genes in the chicken genome shows that the mucin domain of Muc13 is encoded by multiple exons and that ovomucin is part of a locus of related gel-forming mucins. BMC Genomics 2006; 7: 197.","journal-title":"BMC Genomics"},{"key":"BFejhg2011155_CR59","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/mc.20311","volume":"46","author":"U Gopal","year":"2007","unstructured":"Gopal U, Venkatraman J, Niranjali D et al: Interaction of MUC1 with beta-catenin modulates the Wnt target Gene cyclinD1 in H. pylori-induced gastric cancer. Mol Carcinog 2007; 46: 807\u2013817.","journal-title":"Mol Carcinog"},{"key":"BFejhg2011155_CR60","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1242\/dmm.003293","volume":"3","author":"AJ Glading","year":"2010","unstructured":"Glading AJ, Ginsberg MH : Rap1 and its effector KRIT1\/CCM1 regulate beta-catenin signalling. Dis Model Mech 2010; 3: 73\u201383.","journal-title":"Dis Model Mech"},{"key":"BFejhg2011155_CR61","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.cell.2006.10.018","volume":"127","author":"H Clevers","year":"2006","unstructured":"Clevers H : Wnt\/beta-catenin signalling in development and disease. Cell 2006; 127: 469\u2013480.","journal-title":"Cell"},{"key":"BFejhg2011155_CR62","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1083\/jcb.200806024","volume":"183","author":"S Liebner","year":"2008","unstructured":"Liebner S, Corada M, Bangsow T et al: Wnt\/beta-catenin signalling controls development of the blood-brain barrier. J Cell Biol 2008; 183: 409\u2013417.","journal-title":"J Cell Biol"},{"key":"BFejhg2011155_CR63","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.bbamem.2007.08.018","volume":"1778","author":"L Gonzalez-Mariscal","year":"2008","unstructured":"Gonzalez-Mariscal L, Tapia R, Chamorro D : Crosstalk of tight junction components with signalling pathways. Biochim Biophys Acta 2008; 1778: 729\u2013756.","journal-title":"Biochim Biophys Acta"},{"key":"BFejhg2011155_CR64","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1242\/jcs.059329","volume":"123","author":"MG Lampugnani","year":"2010","unstructured":"Lampugnani MG, Orsenigo F, Rudini N et al: CCM1 regulates vascular-lumen organization by inducing endothelial polarity. J Cell Sci 2010; 123: 1073\u20131080.","journal-title":"J Cell Sci"},{"key":"BFejhg2011155_CR65","doi-asserted-by":"publisher","first-page":"13301","DOI":"10.1074\/jbc.C900009200","volume":"284","author":"LE Crose","year":"2009","unstructured":"Crose LE, Hilder TL, Sciaky N et al: Cerebral cavernous malformation 2 protein promotes smad ubiquitin regulatory factor 1-mediated RhoA degradation in endothelial cells. J Biol Chem 2009; 284: 13301\u201313305.","journal-title":"J Biol Chem"},{"key":"BFejhg2011155_CR66","doi-asserted-by":"publisher","first-page":"11760","DOI":"10.1074\/jbc.C109.097220","volume":"285","author":"AL Borikova","year":"2010","unstructured":"Borikova AL, Dibble CF, Sciaky N et al: Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype. J Biol Chem 2010; 285: 11760\u201311764.","journal-title":"J Biol Chem"},{"key":"BFejhg2011155_CR67","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1172\/JCI39679","volume":"120","author":"X Zheng","year":"2010","unstructured":"Zheng X, Xu C, Di Lorenzo A et al: CCM3 signalling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations. J Clin Invest 2010; 120: 2795\u20132804.","journal-title":"J Clin Invest"},{"key":"BFejhg2011155_CR68","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1083\/jcb.200310061","volume":"164","author":"C Preisinger","year":"2004","unstructured":"Preisinger C, Short B, De Corte V et al: YSK1 is activated by the Golgi matrix protein GM130 and plays a role in cell migration through its substrate 14-3-3 {zeta}. J Cell Biol 2004; 164: 1009\u20131020.","journal-title":"J Cell Biol"},{"key":"BFejhg2011155_CR69","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1242\/jcs.061341","volume":"123","author":"M Fidalgo","year":"2010","unstructured":"Fidalgo M, Fraile M, Pires A et al: CCM3\/PDCD10 stabilizes GCKIII proteins to promote Golgi assembly and cell orientation. J Cell Sc 2010; 123: 1274\u20131284.","journal-title":"J Cell Sc"},{"key":"BFejhg2011155_CR70","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1161\/hh1901.097747","volume":"89","author":"PA Rupp","year":"2001","unstructured":"Rupp PA, Little CD : Integrins in vascular development. Circ Res 2001; 89: 566\u2013572.","journal-title":"Circ Res"},{"key":"BFejhg2011155_CR71","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1242\/jcs.115.6.1123","volume":"115","author":"KJ Bayless","year":"2002","unstructured":"Bayless KJ, Davis GE : The Cdc42 and Rac1 GTPases are required for capillary lumen formation in three-dimensional extracellular matrices. J Cell Sci 2002; 115: 1123\u20131136.","journal-title":"J Cell Sci"},{"key":"BFejhg2011155_CR72","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.devcel.2009.01.013","volume":"16","author":"ML Iruela-Arispe","year":"2009","unstructured":"Iruela-Arispe ML, Davis GE : Cellular and molecular mechanisms of vascular lumen formation. Developmental Cell 2009; 16: 222\u2013231.","journal-title":"Developmental Cell"},{"key":"BFejhg2011155_CR73","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nm.1911","volume":"15","author":"KJ Whitehead","year":"2009","unstructured":"Whitehead KJ, Chan AC, Navankasattusas S et al: The cerebral cavernous malformation signalling pathway promotes vascular integrity via Rho GTPases. Nat Med 2009; 15: 177\u2013184.","journal-title":"Nat Med"},{"key":"BFejhg2011155_CR74","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000316851","volume":"48","author":"H Liu","year":"2011","unstructured":"Liu H, Rigamonti D, Badr A et al: Ccm1 regulates microvascular morphogenesis during angiogenesis. J Vasc Res 2011; 48: 130\u2013140.","journal-title":"J Vasc Res"},{"key":"BFejhg2011155_CR75","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1242\/jcs.018093","volume":"122","author":"DS Harburger","year":"2009","unstructured":"Harburger DS, Calderwood DA : Integrin signalling at a glance. J Cell Sci 2009; 122: 159\u2013163.","journal-title":"J Cell Sci"},{"key":"BFejhg2011155_CR76","doi-asserted-by":"publisher","first-page":"10454","DOI":"10.1073\/pnas.180316397","volume":"97","author":"JS Mudgett","year":"2000","unstructured":"Mudgett JS, Ding J, Guh-Siesel L et al: Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. PNAS 2000; 97: 10454\u201310459.","journal-title":"PNAS"},{"key":"BFejhg2011155_CR77","doi-asserted-by":"publisher","first-page":"E16","DOI":"10.3171\/2009.2.FOCUS0923","volume":"26","author":"M Pham","year":"2009","unstructured":"Pham M, Gross BA, Bendok BR et al: Radiosurgery for angiographically occult vascular malformations. Neurosurg Focus 2009; 26: E16.","journal-title":"Neurosurg Focus"},{"key":"BFejhg2011155_CR78","doi-asserted-by":"publisher","first-page":"E805","DOI":"10.1227\/01.NEU.0000343668.44288.18","volume":"64","author":"BA Gross","year":"2009","unstructured":"Gross BA, Batjer HH, Awad IA et al: Brainstem cavernous malformations. Neurosurgery 2009; 64: E805\u2013E818.","journal-title":"Neurosurgery"},{"key":"BFejhg2011155_CR79","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.3171\/2010.5.FOCUS10121","volume":"29","author":"S Yadla","year":"2010","unstructured":"Yadla S, Jabbour PM, Shenkar R et al: Cerebral cavernous malformations as a disease of vascular permeability: from bench to bedside with caution. Neurosurg Focus 2010; 29: E4.","journal-title":"Neurosurg Focus"},{"key":"BFejhg2011155_CR80","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.3171\/2010.6.FOCUS10135","volume":"29","author":"KM Krisht","year":"2010","unstructured":"Krisht KM, Whitehead KJ, Niazi T et al: The pathogenetic features of cerebral cavernous malformations: a comprehensive review with therapeutic implications. Neurosurg Focus 2010; 29: E2.","journal-title":"Neurosurg Focus"},{"key":"BFejhg2011155_CR81","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1084\/jem.20091258","volume":"207","author":"RA Stockton","year":"2010","unstructured":"Stockton RA, Shenkar R, Awad IA et al: Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med 2010; 207: 881\u2013896.","journal-title":"J Exp Med"},{"key":"BFejhg2011155_CR82","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1128\/MCB.25.1.136-146.2005","volume":"25","author":"S Fukuhara","year":"2005","unstructured":"Fukuhara S, Sakurai A, Sano H et al: Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signalling pathway. Mol Cell Biol 2005; 25: 136\u2013146.","journal-title":"Mol Cell Biol"},{"key":"BFejhg2011155_CR83","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nrd2130","volume":"5","author":"S Wilhelm","year":"2006","unstructured":"Wilhelm S, Carter C, Lynch M et al: Discovery and development of sorafenib: A multikinase inhibitor for treating cancer. Nat Rev Drug Discov 2006; 5: 835\u2013844.","journal-title":"Nat Rev Drug Discov"},{"key":"BFejhg2011155_CR84","doi-asserted-by":"publisher","first-page":"12640","DOI":"10.1073\/pnas.1000132107","volume":"107","author":"J W\u00fcstehube","year":"2010","unstructured":"W\u00fcstehube J, Bartol A, Liebler SS et al: Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signalling. PNAS 2010; 107: 12640\u201312645.","journal-title":"PNAS"},{"key":"BFejhg2011155_CR85","first-page":"1166","volume":"44","author":"JL Moriarity","year":"1999","unstructured":"Moriarity JL, Wetzel M, Clatterbuck RE et al: The natural history of cavernous malformations: a prospective study of 68 patients. Neurosurgery 1999; 44: 1166\u20131173.","journal-title":"Neurosurgery"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ejhg2011155","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ejhg2011155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ejhg2011155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T17:19:01Z","timestamp":1686244741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg2011155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,10]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["BFejhg2011155"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2011.155","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,10]]},"assertion":[{"value":"4 January 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}